Walgreens settles New York charges it inflated prices of infant formula By Reuters
[ad_1]
© Reuters. FILE PHOTO: People walk by a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Photo
NEW YORK (Reuters) – Walgreens has settled charges by New York Attorney General Letitia James that the pharmacy chain grossly inflated prices on at least 20 infant formula products in 2022 after a recall by Abbott Labs (NYSE:) led to a nationwide shortage.
Walgreens did not admit or deny wrongdoing in entering an assurance of discontinuance dated March 7 and made public on Monday.
[ad_2]
Source link
© Reuters. FILE PHOTO: People walk by a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Photo
NEW YORK (Reuters) – Walgreens has settled charges by New York Attorney General Letitia James that the pharmacy chain grossly inflated prices on at least 20 infant formula products in 2022 after a recall by Abbott Labs (NYSE:) led to a nationwide shortage.
Walgreens did not admit or deny wrongdoing in entering an assurance of discontinuance dated March 7 and made public on Monday.